- Trials with a EudraCT protocol (999)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
999 result(s) found.
Displaying page 1 of 50.
EudraCT Number: 2016-001935-12 | Sponsor Protocol Number: AIEOP-BFM-ALL-2017 | Start Date*: 2018-07-02 |
Sponsor Name:Universitätsklinikum Schleswig-Holstein, Campus Kiel | ||
Full Title: AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia | ||
Medical condition: acute lymphoblastic leukemia in children and adolescents <18 years of age | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Restarted) AT (Ongoing) IT (Ongoing) SK (Ongoing) CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005452-38 | Sponsor Protocol Number: D910PC00001 | Start Date*: 2022-07-28 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With En... | |||||||||||||
Medical condition: Documented muscle-invasive urothelial carcinoma (UC) of the bladder in cisplatin ineligible patients or Who Refuse Cisplatin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) ES (Ongoing) PT (Ongoing) AT (Ongoing) PL (Ongoing) NL (Ongoing) IT (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002176-41 | Sponsor Protocol Number: 17HH4268 | Start Date*: 2019-09-03 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Imperial College of Science Technology and Medicine | ||||||||||||||||||||||||||||||||||||||
Full Title: PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation (PRESTIGE-AF) | ||||||||||||||||||||||||||||||||||||||
Medical condition: Ischaemic stroke prevention in patients with atrial fibrillation and previous intracerebral haemorrhage | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Restarted) ES (Ongoing) AT (Ongoing) FR (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001076-11 | Sponsor Protocol Number: CTQJ230A12301 | Start Date*: 2019-12-19 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients with establishe... | |||||||||||||
Medical condition: Cardiovascular Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Restarted) AT (Ongoing) GB (GB - no longer in EU/EEA) DK (Ongoing) SK (Ongoing) IT (Ongoing) GR (Ongoing) PT (Ongoing) SE (Ongoing) NL (Ongoing) BG (Ongoing) BE (Ongoing) NO (Ongoing) SI (Ongoing) RO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001363-27 | Sponsor Protocol Number: DAY101-002 | Start Date*: 2023-01-18 | |||||||||||
Sponsor Name:Day One Biopharmaceuticals, Inc. (Day One) | |||||||||||||
Full Title: LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activati... | |||||||||||||
Medical condition: Pediatric low-grade glioma harboring an activating RAF alteration requiring first-line systemic therapy | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) IE (Ongoing) HU (Ongoing) DE (Restarted) NO (Ongoing) BE (Ongoing) FI (Ongoing) AT (Ongoing) SI (Ongoing) GR (Ongoing) DK (Ongoing) CZ (Ongoing) IT (Ongoing) ES (Ongoing) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000803-20 | Sponsor Protocol Number: C1071006 | Start Date*: 2022-11-02 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: MAGNETISMM-6: AN OPEN-LABEL, 2-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) + DARATUMUMAB + LENALIDOMIDE VERSUS DARATUMUMAB + LENA... | |||||||||||||
Medical condition: Multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) ES (Restarted) CZ (Ongoing) BE (Ongoing) DE (Ongoing) FI (Ongoing) HU (Ongoing) FR (Ongoing) GR (Ongoing) DK (Ongoing) AT (Ongoing) IT (Ongoing) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002766-39 | Sponsor Protocol Number: ET13-002 | Start Date*: 2021-02-17 | |||||||||||
Sponsor Name:Centre Leon Berard | |||||||||||||
Full Title: SIOP Ependymoma II - An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with Ependymoma | |||||||||||||
Medical condition: Newly diagnosed with an intracranial or spinal ependymoma (all WHO grades) including ependymoma variants: cellular, papillary, myxopapillary, clear-cell and tanycytic) or anaplastic ependymoma. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) IE (Ongoing) IT (Ongoing) BE (Ongoing) ES (Ongoing) NO (Ongoing) DE (Ongoing) DK (Restarted) FI (Ongoing) CZ (Ongoing) AT (Ongoing) NL (Ongoing) GR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002998-21 | Sponsor Protocol Number: CLEE011O12301C | Start Date*: 2019-02-25 | ||||||||||||||||
Sponsor Name:Novartis Pharma AG | ||||||||||||||||||
Full Title: A phase III, multicenter, randomized, open-label trial toevaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-... | ||||||||||||||||||
Medical condition: hormone receptor-positive, HER2-negative, early breast cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) IE (Ongoing) HU (Ongoing) AT (Ongoing) BE (Ongoing) DE (Restarted) FR (Ongoing) PL (Ongoing) IT (Ongoing) RO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003342-25 | Sponsor Protocol Number: P170604J | Start Date*: 2018-09-07 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Long-term treatment of cancer associated VTE Optimal dose of apixaban API-CAT STUDY for APIxaban Cancer Associated Thrombosis | |||||||||||||
Medical condition: Patients with breast, prostate, and colorectal active cancer, with objectively documented index event of symptomatic or incidental proximal DVT or symptomatic or incidental PE, after 6 months of an... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Temporarily Halted) PL (Ongoing) ES (Restarted) GB (GB - no longer in EU/EEA) BE (Ongoing) GR (Restarted) AT (Ongoing) NL (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001489-17 | Sponsor Protocol Number: SIOPENRNET003 | Start Date*: 2006-11-17 |
Sponsor Name:St. Anna Kinderkrebsforschung e.V. | ||
Full Title: High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) | ||
Medical condition: High Risk Neuroblastoma | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) ES (Restarted) GB (GB - no longer in EU/EEA) BE (Ongoing) DK (Restarted) IE (Ongoing) HU (Ongoing) FI (Ongoing) SI (Completed) PL (Ongoing) GR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002195-13 | Sponsor Protocol Number: CNTO1959CRD3001 | Start Date*: 2019-06-05 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Seve... | |||||||||||||
Medical condition: Moderately to Severely Active Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Restarted) BE (Ongoing) AT (Completed) LT (Restarted) CZ (Ongoing) SK (Ongoing) NL (Ongoing) LV (Ongoing) ES (Ongoing) PL (Ongoing) GR (Temporarily Halted) PT (Restarted) HR (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002769-44 | Sponsor Protocol Number: ESAP | Start Date*: 2015-09-28 | |||||||||||
Sponsor Name:Medical University of Graz | |||||||||||||
Full Title: Efficacy and safety of an accelerated outpatient protocol for hymenoptera venom immunotherapy | |||||||||||||
Medical condition: Immunotherapy against systemic anaphylactic sting reactions | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000624-33 | Sponsor Protocol Number: HO156_AMLSG28/18 | Start Date*: 2019-08-01 | ||||||||||||||||
Sponsor Name:HOVON Foundation | ||||||||||||||||||
Full Title: A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by one-year maintenance in patients with ne... | ||||||||||||||||||
Medical condition: Previously untreated Acute Myeloid Leukemia (AML) or Myelodysplastic syndromes with excess blasts-2 (MDS-EB2) with FLT3 mutations | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) SE (Restarted) LT (Ongoing) BE (Ongoing) FI (Temporarily Halted) FR (Ongoing) IE (Restarted) AT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004297-26 | Sponsor Protocol Number: C19-29 | Start Date*: 2020-04-17 |
Sponsor Name:Institut National de la Santé et de la Recherche Médicale (INSERM) | ||
Full Title: Prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen | ||
Medical condition: Patent ductus arteriosus | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) EE (Ongoing) IE (Restarted) FI (Ongoing) BE (Ongoing) PT (Restarted) SE (Ongoing) HU (Ongoing) DK (Completed) GB (Not Authorised) NO (Completed) AT (Ongoing) GR (Ongoing) PL (Ongoing) IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003205-25 | Sponsor Protocol Number: BT–L-CsA–302–DLT | Start Date*: 2019-01-09 |
Sponsor Name:BREATH Therapeutics Inc. | ||
Full Title: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PA... | ||
Medical condition: Bronchiolitis Obliterans Syndrome in Patients post Double Lung Transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) DE (Restarted) AT (Ongoing) BE (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004187-56 | Sponsor Protocol Number: HIT-HGG-2013 | Start Date*: 2017-04-24 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: International cooperative Phase III trial of the HIT-HGG study group for the treatment of high grade glioma, diffuse intrinsic pontine glioma, and gliomatosis cerebri in children and adolescents < ... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: First-line therapy of newly diagnosed, previously untreated high grade glioma, diffuse pontine glioma, and gliomatosis cerebri in children and adolescents <18 years. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Restarted) AT (Ongoing) NL (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003526-88 | Sponsor Protocol Number: CZAR-1 | Start Date*: 2020-12-15 | |||||||||||
Sponsor Name:University Hospital Ulm | |||||||||||||
Full Title: Efficacy and safety of Carfilzomib in combination with Ibrutinib vs. Ibrutinib alone in Waldenström’s Macroglobulinemia (CZAR-1) | |||||||||||||
Medical condition: Waldenström's Macroglobulinemia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Restarted) GR (Ongoing) AT (Ongoing) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005078-70 | Sponsor Protocol Number: ACTICCA-1 | Start Date*: 2014-01-16 | ||||||||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | ||||||||||||||||||
Full Title: Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) ... | ||||||||||||||||||
Medical condition: Cholangiocarcinoma and gallbladder carcinoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Restarted) NL (Ongoing) GB (GB - no longer in EU/EEA) DK (Completed) AT (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005098-19 | Sponsor Protocol Number: 1414-ROG-GUCG | Start Date*: 2017-09-28 | |||||||||||
Sponsor Name:European Organisation for Research and Treatment of Cancer (EORTC) | |||||||||||||
Full Title: Phase IIIb randomized trial comparing irradiation plus long term adjuvant androgen deprivation with GnRH antagonist versus GnRH agonist plus flare protection in patients with very high risk localiz... | |||||||||||||
Medical condition: very high risk localized or locally advanced prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: BE (Ongoing) ES (Restarted) FR (Ongoing) AT (Completed) DE (Ongoing) GB (GB - no longer in EU/EEA) DK (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004002-25 | Sponsor Protocol Number: CNTO1959UCO3001 | Start Date*: 2019-10-15 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active... | |||||||||||||
Medical condition: Moderately to Severely Active Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Restarted) PT (Ongoing) PL (Ongoing) HU (Ongoing) FR (Ongoing) GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Ongoing) BE (Ongoing) NL (Ongoing) BG (Ongoing) AT (Completed) SK (Ongoing) LV (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.